Viewing Study NCT01066195


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-01-29 @ 4:46 AM
Study NCT ID: NCT01066195
Status: UNKNOWN
Last Update Posted: 2010-02-10
First Post: 2010-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Sponsor: Samsung Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2008-04-030
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Myungju Ahn Ph.D., M.D.
Old Organization: Samsung Medical Center

Collaborators